Muscle Growth
Tesamorelin
May help reduce belly fat and support lean muscle.
How it works
Tesamorelin
Coming soon. Tesamorelin is not yet available to order while we finalize sourcing through our US pharmacy network. The information below is here so you can decide whether it belongs in your plan once it arrives.
At a glance
- The most proven medication in its class: FDA approved in 2010 under the brand name Egrifta® and still on the market today
- Reduced deep belly fat (visceral fat) by 15.2% over 26 weeks in its 412-person phase 3 trial, while the placebo group gained fat
- A growth-hormone releasing analog like sermorelin, but longer-acting and backed by far larger trials
- Targets visceral fat, the metabolically dangerous fat around your organs, not just the number on the scale
- Prescribed by a US-licensed physician, with medical supervision included for the length of your treatment
What it is
Tesamorelin is a growth-hormone releasing hormone (GHRH) analog: a stabilized copy of the full 44-amino-acid signal your brain uses to tell the pituitary gland to release growth hormone. It is the most clinically validated compound in its class. The FDA approved it in 2010 under the brand name Egrifta® to reduce excess abdominal fat in HIV patients with treatment-related fat redistribution, and it remains an approved, marketed drug today. Ours is a compounded version prepared by a licensed US compounding pharmacy, prescribed off-label for visceral fat reduction after a licensed clinician reviews your intake.
How it works
Tesamorelin works on the same principle as sermorelin: it stimulates your own pituitary to release growth hormone in natural pulses rather than injecting growth hormone directly. The difference is durability. Tesamorelin is chemically stabilized so the body breaks it down more slowly, which produces a stronger, longer growth hormone signal. That signal shifts your metabolism toward burning visceral fat, the deep abdominal fat that wraps around your organs. Visceral fat is the fat that matters most for health: it is metabolically active in the wrong direction, feeding inflammation and insulin resistance, and a waistline can hide a lot of it even in men who do not look heavy.
What the research shows
Tesamorelin has the strongest evidence of any growth-hormone releasing peptide. In its pivotal phase 3 trial, 412 patients received tesamorelin or placebo for 26 weeks: visceral fat fell by 15.2% in the tesamorelin group while the placebo group gained 5%, and a 52-week extension confirmed the effect held with continued use. Follow-up research has also shown reductions in liver fat, which matters because fatty liver is one of the most common silent metabolic conditions in men over 35. Two honest caveats. The pivotal trials were run in HIV patients with treatment-related fat gain, so applying the results to general visceral fat is an extrapolation your clinician will discuss with you. And the trials show that when treatment stops, visceral fat gradually returns toward baseline, so tesamorelin works while you use it and is best paired with the training and nutrition habits that hold the result.
What to expect
Tesamorelin is a small daily injection, typically taken in the evening. Change builds over months, not weeks: the phase 3 result above reflects 26 weeks of consistent use, and body composition responds fastest when treatment is paired with resistance training and adequate protein. Many patients notice sleep and recovery improvements earlier, consistent with restored growth hormone signaling. After checkout, a licensed clinician reviews your intake before anything ships. Nothing is fulfilled without that review.
Side effects and who it's not for
The most common side effects are injection-site reactions such as redness or irritation, joint aches, and mild fluid retention, all consistent with increased growth hormone signaling and usually transient. Tesamorelin can nudge blood sugar upward slightly, so your clinician will consider your metabolic status and may monitor glucose. It is not for you if you have an active cancer, a pituitary condition, or if you are pregnant. Your clinician screens for all of this during review.
FAQ
Is tesamorelin FDA approved?
The brand-name product Egrifta® is FDA approved and has been since 2010, for reducing excess abdominal fat in HIV patients with treatment-related lipodystrophy. Our version is prepared by a licensed US compounding pharmacy and prescribed off-label for visceral fat outside that specific population. Compounded medications themselves are not FDA-approved, and the FDA does not verify their safety, effectiveness, or quality. That is why we built our own quality chain: US-licensed physicians, a US compounding pharmacy, and independent third-party testing of every batch.
Tesamorelin or sermorelin: which one is right for me?
They work on the same pathway. Sermorelin is the gentler, older, less expensive option with a lighter evidence base; tesamorelin is stronger, longer-acting, and carries the only FDA approval and large-trial data in the class, with visceral fat as its proven target. If your goal is specifically reducing deep belly fat, tesamorelin has the receipts. Your clinician will help you choose based on your goals, budget, and labs.
What is visceral fat and why should I care?
It is the fat stored deep in your abdomen around your organs, and it behaves differently from the fat under your skin. Visceral fat actively promotes inflammation and insulin resistance and is linked to heart disease, diabetes, and fatty liver. You can carry a lot of it without looking obviously overweight, which is why waist circumference and body composition tell you more than the bathroom scale.
How fast will I see results?
Plan in months. The pivotal trial ran 26 weeks, and that is a realistic frame for meaningful visceral fat change. This is not a rapid weight-loss drug like a GLP-1; it is a targeted body-composition tool that rewards consistency.
Why is it more expensive than some offers I see online?
Because you are not just buying a vial. Your treatment includes a consultation with a highly educated US-licensed physician, ongoing medical supervision, and medication from a US compounding pharmacy whose batches are third-party tested. Peptides are one of the worst corners of the internet for gray-market products of unknown purity and potency. We deliberately built a premium offering to cut through that: verified medication, real doctors, and supervision included in the price.
Does insurance cover this?
No. In our telehealth setup, insurance coverage is unfortunately not possible, so you pay for your treatment directly. What you get in return is the complete service: your physician consultation, ongoing medical supervision, and third-party tested medication are all included in the price.
What happens if I stop?
The trials are honest about this and so are we: visceral fat gradually returns toward baseline after stopping. That is why we treat tesamorelin as one tool inside a program. The training, protein, and sleep habits you build during treatment are what hold the result, and your clinician can help you decide between continuing, pausing, or transitioning to a maintenance approach.
All trademarks are the property of their respective owners. This product is not affiliated with, endorsed by, or sponsored by the makers of the brand-name medications referenced above.
-
Clinician guided
Every protocol is reviewed by a licensed provider before fulfillment.
-
Discreet delivery
Medications ship in plain packaging with free expedited options where available.
-
Ongoing care
Stay supported with check-ins, dosage guidance, and care team messaging.